Paysign, Inc. (NASDAQ:PAYS – Get Free Report)’s share price hit a new 52-week high on Wednesday. The company traded as high as $15.62 and last traded at $15.48, with a volume of 799,987 shares. The stock had previously closed at $15.17.
Wall Street Analyst Weigh In
Several brokerages recently issued reports on PAYS. Wall Street Zen downgraded Paysign from a “strong-buy” rating to a “buy” rating in a report on Sunday, August 16th. Weiss Ratings raised Paysign from a “buy (b-)” rating to a “buy (b)” rating in a research report on Thursday, October 8th. DA Davidson boosted their price objective on Paysign from $12.00 to $15.00 and gave the stock a “buy” rating in a research note on Wednesday, September 30th. Lake Street Capital boosted their price objective on Paysign from $13.00 to $15.00 and gave the stock a “buy” rating in a research note on Tuesday, September 15th. Finally, Barrington Research set a $15.00 target price on Paysign in a research report on Tuesday, August 11th. Three research analysts have rated the stock with a Buy rating. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of $15.00.
Check Out Our Latest Report on Paysign
Paysign Stock Performance
Paysign (NASDAQ:PAYS – Get Free Report) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.06 by $0.05. The company had revenue of $28.25 million during the quarter, compared to the consensus estimate of $26.36 million. Paysign had a net margin of 15.67% and a return on equity of 30.13%. Paysign has set its FY 2026 guidance at 0.350-0.370 EPS and its Q3 2026 guidance at 0.090-0.100 EPS. On average, equities analysts predict that Paysign, Inc. will post 0.58 EPS for the current fiscal year.
Insider Activity
In related news, insider Michael C. Ngo sold 79,925 shares of the firm’s stock in a transaction on Wednesday, September 9th. The shares were sold at an average price of $12.74, for a total transaction of $1,018,244.50. Following the completion of the sale, the insider directly owned 2,350,000 shares of the company’s stock, valued at approximately $29,939,000. This trade represents a 3.29% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Joan M. Herman sold 38,900 shares of Paysign stock in a transaction on Wednesday, September 16th. The stock was sold at an average price of $11.74, for a total transaction of $456,686.00. Following the sale, the executive vice president directly owned 609,421 shares in the company, valued at $7,154,602.54. This trade represents a 6.00% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 444,904 shares of company stock valued at $5,328,124 over the last ninety days. 24.50% of the stock is owned by company insiders.
Hedge Funds Weigh In On Paysign
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Tidal Investments LLC purchased a new stake in shares of Paysign during the second quarter worth about $121,000. Connective Capital Management LLC acquired a new position in shares of Paysign in the second quarter worth about $327,000. Corient Private Wealth LP lifted its stake in shares of Paysign by 69.8% in the second quarter. Corient Private Wealth LP now owns 30,159 shares of the company’s stock worth $247,000 after acquiring an additional 12,396 shares in the last quarter. Punch & Associates Investment Management Inc. acquired a new position in shares of Paysign in the second quarter worth about $16,983,000. Finally, Bank of America Corp DE acquired a new position in shares of Paysign in the second quarter worth about $335,000. 25.89% of the stock is owned by hedge funds and other institutional investors.
About Paysign
Paysign, Inc (NASDAQ: PAYS) provides prepaid payment and financial technology solutions, with a focus on healthcare, pharmaceutical and other specialized markets. Its platform supports the issuance and management of prepaid cards, digital payments, account services and related payment-processing activities.
The company’s healthcare offerings include patient assistance and copay programs that help pharmaceutical manufacturers distribute financial support to eligible patients. Paysign also provides payment and card solutions for plasma collection centers, including programs used to compensate plasma donors.
Featured Stories
- Five stocks we like better than Paysign
- A Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?
- Could T-Mobile’s Satellite Competition Fears Create a Buying Opportunity?
- Surgical Precision, Sustainable Returns: Johnson & Johnson Secures Its Cash Flow Runway
- Tesla’s Robotaxi Lands in Paris—But Europe’s Real Fight Is Over Cheap EVs
Receive News & Ratings for Paysign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paysign and related companies with MarketBeat.com's FREE daily email newsletter.
